Acerus Pharmaceuticals entered into an amended agreement related to its existing credit facility with SWK, changing four aspects of its terms and conditions.
Hooper Holmes d/b/a Provant Health entered into an asset purchase agreement with Summit Health as part of a 363 sale. SWK Holdings and CNH Finance agreed to provide the company with up to $13.6 million in financing to keep the business operating until the sale closes.
Hooper Holmes and Provant Health Solutions will combine in an all-stock transaction. SWK Holdings, a specialty finance company focused on the healthcare sector, is providing a $6.5 million term loan for working capital.
Parnell Pharmaceuticals entered into a $20 million senior secured term loan agreement with SWK Holdings. A portion of the proceeds will be used to repay a term loan with MidCap Financial.
PDI acquired RedPath Integrated Pathology to expand the oncology diagnostic product portfolio of subsidiary Interpace Diagnostics. In connection with the acquisition, PDI secured a term loan from SWK Holdings.
SWK Holdings said it closed a credit facility of up to $30 million from a fund affiliated with Carlson Capital. The credit facility has a four-year term and provides financing against all of SWK’s assets.